ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,789.60
      0.57%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      -0.63%
      Bitcoin
      57,632.54
      0.49%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Kodiak Sciences Inc (KOD)

      7. Kodiak Sciences Inc (KOD) News

      KOD

      Kodiak Sciences (KOD)

      Kodiak Sciences Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:KOD
      DateTimeSourceHeadlineSymbolCompany
      09/07/20224:05PMPR Newswire (US)Kodiak Sciences to Present at the 2022 Morgan Stanley Healthcare ConferenceNASDAQ:KODKodiak Sciences Inc
      08/18/20225:47PMPR Newswire (US)Kodiak Sciences Announces Upcoming Presentations of Tarcocimab Tedromer (KSI-301) Phase 3 BEACON Study Results in Retinal Vein Occlusion (RVO)NASDAQ:KODKodiak Sciences Inc
      08/15/202212:45PMTipRanksMorgan Stanley Sticks to Their Hold Rating for Kodiak Sciences (KOD)NASDAQ:KODKodiak Sciences Inc
      08/10/202212:36PMTipRanksChardan Capital Sticks to Their Buy Rating for Kodiak Sciences (KOD)NASDAQ:KODKodiak Sciences Inc
      08/09/20225:04PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:KODKodiak Sciences Inc
      08/09/20224:33PMPR Newswire (US)Kodiak Sciences Announces Second Quarter 2022 Financial Results and Recent Business HighlightsNASDAQ:KODKodiak Sciences Inc
      08/09/202212:35PMTipRanksGoldman Sachs Sticks to Their Hold Rating for Kodiak Sciences (KOD)NASDAQ:KODKodiak Sciences Inc
      08/08/20227:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KODKodiak Sciences Inc
      08/08/20226:30AMPR Newswire (US)Kodiak Sciences Reports Positive Topline Results from BEACON Phase 3 Study of Tarcocimab Tedromer (KSI-301) in Patients with Retinal Vein OcclusionNASDAQ:KODKodiak Sciences Inc
      08/05/20224:30PMPR Newswire (US)Kodiak Sciences Completes Enrollment in GLOW Phase 3 Clinical Trial of Tarcocimab Tedromer (KSI-301) in Patients with Non-Proliferative Diabetic RetinopathyNASDAQ:KODKodiak Sciences Inc
      07/25/20228:36AMTipRanksKodiak Sciences (KOD) Gets a Buy Rating from JefferiesNASDAQ:KODKodiak Sciences Inc
      07/08/20225:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      07/08/20225:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      07/05/20225:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      07/05/20225:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      07/05/20225:23PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      07/05/20225:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      06/17/20227:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      06/08/20226:01AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KODKodiak Sciences Inc
      06/06/20225:11PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:KODKodiak Sciences Inc
      06/06/20225:09PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      05/27/20225:45PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      05/27/20228:00AMPR Newswire (US)Kodiak Sciences to Present at the Jefferies Global Healthcare ConferenceNASDAQ:KODKodiak Sciences Inc
      05/24/202212:40PMTipRanksKodiak Sciences (KOD) Gets a Hold Rating from Goldman SachsNASDAQ:KODKodiak Sciences Inc
      05/19/20228:00AMPR Newswire (US)Grand Opening of Kodiak Sciences' Purpose-built Bioconjugation Facility to Support Potential Commercial Manufacture of KSI-301, an Antibody Biopolymer Conjugate for Retinal DiseasesNASDAQ:KODKodiak Sciences Inc
      05/18/20225:31PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:KODKodiak Sciences Inc
      05/17/20228:43AMTipRanksKodiak Sciences (KOD) Gets a Hold Rating from Morgan StanleyNASDAQ:KODKodiak Sciences Inc
      05/12/20228:23AMTipRanksJ.P. Morgan Maintains a Hold Rating on Kodiak Sciences (KOD)NASDAQ:KODKodiak Sciences Inc
      05/11/202212:45PMTipRanksGoldman Sachs Maintains a Hold Rating on Kodiak Sciences (KOD)NASDAQ:KODKodiak Sciences Inc
      05/10/20224:19PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:KODKodiak Sciences Inc
       Showing the most relevant articles for your search:NASDAQ:KOD

      Your Recent History

      BIT
      UC0JMY
      Unicredit Bank
      BIT
      I07230
      INTESA SANPAOLO
      Delayed Upgrade Clock